ACTRN12611000450910已完成2 期
Maxi-Analgesic Dose Response Study: A double-blind, placebo-controlled, randomized, parallel group comparison of the effects of diferent paracetamol + ibuprofen combination doses and placebo in participants with pain from removal of 2-4 third molars.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 159
研究概览
简要总结
All the doses (full dose, half dose and quarter dose) of this fixed dose combination (paracetamol 1000mg + ibuprofen 300mg) provide safe and superior pain relief to placebo in adults for post-operative dental surgery pain relief.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 16 Years 至 60 Years（—）
- 性别
- All
入选标准
- •1)Provide written informed consent before initiation of any study-related procedures (including the willingness to stay at the hospital up to 6 hours after the surgery).
- •2)Males and females aged at least 16 years and not more than 60 years old on the day of consent.
- •3)Undergoing oral surgery for the extraction of 2-4 impacted 3rd molar teeth, one of which must be mandibular and require bone removal. The molars removed, are either bilateral or ipsilateral.
- •4)A resting VAS pain intensity score at baseline (within 6 hours following completion of surgery) of greater than or equal to 50mm on a 100mm VAS scale with 0 ( no pain) and 100 (worst pain imaginable).
排除标准
- •Study contra-indications
- •1)Has taken any NSAID or paracetamol within 12 hours prior to the start of surgery other than aspirin less than or equal to 150mg/day.
- •2)Subjects who have received any anesthetics from midnight the night prior to surgery, except for lidocaine with epinephrine, nitrous oxide, diazepam (Valium [Registered Trademark]), methohexitol (Brevital[Registered Trademark]).
- •3)Hypersensitivity to opioids
- •4)Known to be pregnant or possibly pregnant.
- •5)Women of childbearing potential who are unwilling to take adequate contraceptive precautions, i.e., a hormonal contraceptive, an intrauterine device, double-barrier method, or abstinence (should the subject become sexually active, she must agree to use a double-barrier method of contraception). A woman of childbearing potential is defined as any female who is less than 2 years post-menopausal or has not undergone a partial or total hysterectomy or surgical sterilization, e.g., bilateral tubal ligation, bilateral oophorectomy.
- •6)Women of childbearing potential who are unwilling to undergo a urine pregnancy test
- •7)Suffering from a neurological disorder relating to pain perception or any acute or chronic condition that, in the opinion of the investigator, makes the subject unsuitable from an efficacy or safety perspective.
- •8)In the opinion of the investigator, unable to understand the visual analogue pain score or comply with the protocol requirements.
- •9)Currently or in the last 30 days, has been in a clinical trial involving another study drug.
- •10)Currently treated with an ACE inhibitor, warfarin, steroid (other than nasal steroids or topical steroids with the approval of the investigator), cyclosporin, tacrolimus or methotrexate, or any other medication felt by the investigator to interfere with safety or efficacy evaluations.
- •11)Participant weight < 50kg.
- •12)Suffering from any other diseases or condition which, in the opinion of the investigator, means that it would not be in the participant’s best interests to participate in this study.
- •NSAID and/or paracetamol contra-indications
- •13)Hypersensitivity to aspirin or other NSAID.
- •14)Hypersensitivity to paracetamol.
- •15)Severe known haemopoetic, renal or hepatic disease, or immunosuppressed.
- •16)History of gastric ulceration or other GI disorders that, in the opinion of the investigator make the subject unsuitable (e.g., frequent treatment of GERD, inflammatory bowel disease, etc.).
- •17)History of severe asthma defined as asthma requiring frequent or ongoing treatment to control symptoms. Exercise-induced asthma or mild asthma not requiring ongoing treatment may not be exclusionary at the discretion of the investigator.
研究者
相似试验
已完成
不适用
The Median Effective Dose (ED50) of Paracetamol and Morphine : A Study of Interaction StudyPostoperative PainNCT01366313Procare Riaya Hospital90
已完成
2 期
Maxigesic Oral Suspension for Children undergoing TonsillectomyACTRN12615000456550AFT pharmaceuticals Ltd253
已完成
3 期
Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar ExtractionAcute PainNCT04622735Unither Pharmaceuticals, France321
撤回
1 期
A Study to Compare Two Paracetamol TabletsHealthy SubjectsNCT01381640GlaxoSmithKline
已完成
1 期
A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol FormulationsHealthy SubjectsNCT01476189GlaxoSmithKline28